Skip to content

Clinical trials

Phase 2 Schizophrenia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 2 Country / region: Germany Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20061
20073
20083
20091
20102
20111
20141
20151
20161
20171
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S4
University of Cologne3
Boehringer Ingelheim2
Central Institute of Mental Health, Mannheim2
Denovo Biopharma LLC2
Pfizer2
AstraZeneca1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia21
Psychotic Disorders3
Schizophrenia, Paranoid2
Dementia1
Hallucinations1
Illusions1
Mental Disorders1
Neuroleptic Malignant Syndrome1
Schizophrenia Spectrum and Other Psychotic Disorders1
Schizophrenia, Catatonic1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.